On ECHEMI
Home > Drugs > Alfuzosin hydrochloride Registered Holders
Alfuzosin hydrochloride structure

Alfuzosin hydrochloride structure

Alfuzosin hydrochloride

Alfuzosin hydrochloride is an α1 adrenergic receptor antagonist used to treat benign prostatic hyperplasia (BPH).Target: α1 adrenergic receptorAlfuzosin, a new quinazoline derivative, acts as a selective and competitive antagonist of alpha 1-adrenoceptor-mediated contraction of prostatic, prostatic capsule, bladder base and proximal urethral smooth muscle, thereby reducing the tone of these structures. Consequently, urethral pressure and resistance, bladder outlet resistance, bladder ins

Find 24 Related Holders

CIPLA LIMITED
European Union European Union

API Registration Country

API Inactive
GLENMARK PHARMACEUTICALS LIMITED
European Union European Union

API Registration Country

API Inactive
SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
European Union European Union

API Registration Country

API Inactive
SHANDONG NEW TIME PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Alfuzosin hydrochloride
View 77 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.